Global CD4 and CD8 T cell response patterns
. | . | Patients responding to . | . | |
---|---|---|---|---|
Responding T cell subset . | . | pp65 pool . | IE-1 pool . | |
CD4 T cells | 23 (85%) | 11 (41%)a | ||
Median frequencies (range) | day 0 | 0.27 (0.02–17.23) | 0.04 (0.01–0.16) | |
In % of total CD4 T cells | 3–4 mo | 0.28 (0.03–16.89) | 0.08 (0.05–0.19) | |
Response was dominant inb | 22 | 0 | ||
CD8 T cells | 27 (100%) | 20 (74%) | ||
Median frequencies (range) | day 0 | 0.44 (0.02–8.06) | 0.97 (0.01–10.81) | |
In % of total CD8 T cells | 3–4 mo | 0.55 (0.04–13.01) | 1.05 (0.03–15.47) | |
Response was dominant inb | 17 | 9 |
. | . | Patients responding to . | . | |
---|---|---|---|---|
Responding T cell subset . | . | pp65 pool . | IE-1 pool . | |
CD4 T cells | 23 (85%) | 11 (41%)a | ||
Median frequencies (range) | day 0 | 0.27 (0.02–17.23) | 0.04 (0.01–0.16) | |
In % of total CD4 T cells | 3–4 mo | 0.28 (0.03–16.89) | 0.08 (0.05–0.19) | |
Response was dominant inb | 22 | 0 | ||
CD8 T cells | 27 (100%) | 20 (74%) | ||
Median frequencies (range) | day 0 | 0.44 (0.02–8.06) | 0.97 (0.01–10.81) | |
In % of total CD8 T cells | 3–4 mo | 0.55 (0.04–13.01) | 1.05 (0.03–15.47) | |
Response was dominant inb | 17 | 9 |